Institut Claudius Regaud
Clinical trials sponsored by Institut Claudius Regaud, explained in plain language.
-
Could less chemo be just as effective? new trial for head and neck cancer
Disease control Recruiting nowThis study is for people with a type of head and neck cancer that has come back or spread. It tests whether giving only 4 cycles of chemotherapy (instead of the usual 6) along with the immunotherapy drug pembrolizumab can still work well while causing fewer side effects. About 86…
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New chemo combo could curb sarcoma spread in High-Risk patients
Disease control Recruiting nowThis study tests whether adding 4 cycles of chemotherapy around the time of surgery can help prevent cancer from spreading in people with high-risk soft tissue sarcoma. About 600 participants will be screened, and those with a high-risk genetic marker will be randomly assigned to…
Phase: PHASE3 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Lymph node surgery may boost cervical cancer treatment
Disease control Recruiting nowThis study looks at whether surgically removing para-aortic lymph nodes before standard chemoradiation can improve disease-free survival in people with stage IIIC1 cervical cancer. About 510 participants will be randomly assigned to either standard treatment or surgery plus tailo…
Phase: PHASE3 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 12, 2026 12:11 UTC
-
New skin flap could spare patients extra surgical wounds
Disease control Recruiting nowThis study tests a new surgical technique that uses skin from the groin area (external pudendal flap) to rebuild the mouth or throat after cancer removal. The goal is to see if this method is safe and causes fewer problems at the donor site compared to standard flaps. Up to 40 ad…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC
-
Radiation boost may extend life for bladder cancer patients with few remaining tumors
Disease control Recruiting nowThis study looks at whether adding focused radiation to standard treatment can help people with advanced bladder cancer live longer. It includes patients whose cancer has spread but who have three or fewer remaining tumors after initial chemotherapy. The goal is to see if zapping…
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
Cancer care goes home: study tests nurse visits to cut hospital trips
Symptom relief Recruiting nowThis study is testing a new way to manage care for 33 cancer patients who take oral chemotherapy at home. Instead of going to the hospital every month just to pick up medicine, a nurse will visit them at home twice in six months. An advanced practice nurse will coordinate everyth…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Symptom relief
Last updated Jun 16, 2026 23:04 UTC
-
New shorter radiation aims to help older sarcoma patients heal better after surgery
Symptom relief Recruiting nowThis study tests a shorter course of radiation given before surgery for soft tissue sarcoma in patients aged 70 and older, or those 65 and older who are considered fragile. The goal is to see if this approach reduces major wound healing problems after surgery. About 48 participan…
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Symptom relief
Last updated Jun 15, 2026 19:08 UTC
-
Pre-surgery rehab boosts recovery for sarcoma patients
Symptom relief Recruiting nowThis study tests if a personalized program of physical therapy, exercise, and nutrition before surgery can improve arm or leg function and quality of life for people with bone or soft-tissue sarcoma. About 53 participants will be followed for up to 24 months after surgery. The go…
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Symptom relief
Last updated Jun 15, 2026 19:08 UTC
-
Hypnosis may ease anxiety during cancer radiation
Symptom relief Recruiting nowThis study looks at whether adding medical hypnosis to relaxing music can lower anxiety in cancer patients who are moderately to very anxious during their radiation therapy. About 45 adults with solid tumors will be randomly assigned to either listen to music alone or listen to m…
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Symptom relief
Last updated Jun 15, 2026 18:56 UTC
-
Scientists create detailed atlas of breast cancer cell fat and proteins
Knowledge-focused Recruiting nowThis study collects tissue samples from 1,050 people with early or metastatic breast cancer to map how fat is stored in cells and how proteins are arranged. The goal is to better understand differences between breast cancer subtypes. Participants provide samples during routine ca…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 16, 2026 23:07 UTC
-
Can herbs and supplements boost cancer pill adherence?
Knowledge-focused Recruiting nowThis study explores whether using alternative and complementary therapies, like turmeric supplements, affects how well early-stage breast cancer patients stick to their tamoxifen treatment. Researchers will follow 200 patients for one day to measure medication adherence and tamox…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 16, 2026 23:04 UTC
-
770 cancer patients join quest to unlock immunotherapy secrets
Knowledge-focused Recruiting nowThis study looks at how the immune system responds to immunotherapy drugs in people with advanced solid cancers like lung, head and neck, melanoma, and bladder cancer. Researchers will collect tumor and blood samples to find biological markers that predict whether the treatment w…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:55 UTC
-
Scientists hunt for clues to why some brain tumors resist electric field therapy
Knowledge-focused Recruiting nowThis study collects blood and tumor samples from 80 people with newly diagnosed glioblastoma to find biological markers that predict how well the tumor responds to Tumor Treating Fields (TTFields). Participants receive standard treatment plus TTFields, and samples are taken befor…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:54 UTC
-
Blood test may predict success of targeted radiation for gut tumors
Knowledge-focused Recruiting nowThis study looks at whether a score based on two common blood markers (CRP and albumin) can predict how well patients with advanced intestinal neuroendocrine tumors respond to a type of radiation therapy called Lu-177 oxodotreotide. Researchers will follow 150 patients for 36 mon…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC
-
New study tracks memory loss in kids after brain radiation
Knowledge-focused Recruiting nowThis study looks at how radiation to the brain affects memory in children who had a brain tumor. Researchers will test memory and thinking skills in 130 children ages 4 to 12, starting 2 years after radiation and again 2 years later. The goal is to learn which parts of the brain …
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC
-
Gene mutation study aims to predict blood cancer risk in families
Knowledge-focused Recruiting nowThis study looks at families who carry a change in the DDX41 gene, which may increase the risk of blood cancers. Researchers will track up to 910 people over time to see how many develop blood diseases and at what age. The goal is to create better guidelines for monitoring and co…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC
-
600 ovarian cancer patients help unlock secrets of drug resistance
Knowledge-focused Recruiting nowThis study follows 600 people with epithelial ovarian cancer to find out why some tumors stop responding to platinum-based chemotherapy. Participants receive standard treatment and provide blood, tumor, and fluid samples over 5 years. No new drugs are tested; the goal is to colle…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC
-
Does your weight change how this breast cancer drug works?
Knowledge-focused Recruiting nowThis study looks at how body weight affects the amount of a breast cancer drug (Trastuzumab-Deruxtecan) in the blood and its side effects. Researchers will compare normal-weight and overweight/obese patients with advanced breast cancer. The goal is to see if weight changes drug e…
Phase: PHASE4 • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC
-
Blood test may predict ovarian cancer progression earlier
Knowledge-focused Recruiting nowThis study looks at whether a simple blood test can spot changes in the BRCA gene that might signal ovarian cancer is getting worse. Researchers will collect blood samples from 130 patients with BRCA-mutated ovarian cancer who are taking a maintenance drug called Olaparib (someti…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC
-
Massive study aims to unlock immune secrets of 7 cancers
Knowledge-focused Recruiting nowThis study is collecting tumor and blood samples from 1,100 people with various cancers (head and neck, ovarian, cervical, lung, brain, and anal) to measure how active certain immune cells are. The goal is to better understand why some cancers trigger a stronger immune response t…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
Scientists hunt for clues to PARP drug resistance in breast cancer
Knowledge-focused Recruiting nowThis study aims to understand why some breast cancers with BRCA1/2 mutations stop responding to PARP inhibitor drugs. Researchers will analyze tumor and blood samples from 120 people with advanced breast cancer to look for specific genetic markers linked to drug resistance. The g…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
500 rare sarcoma patients enrolled in immune study
Knowledge-focused Recruiting nowThis study aims to better understand the immune system's role in rare soft tissue sarcomas. Researchers will collect medical information and tumor samples from 500 patients (400 new and 100 from past records) to analyze immune markers and genetic signatures. The goal is to learn …
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:07 UTC
-
Blood test vs. PET scan: new study aims to spot prostate cancer spread
Knowledge-focused Recruiting nowThis study looks at whether a blood test (liquid biopsy) can detect prostate cancer cells as well as a special PET scan. Researchers will compare results from 80 men with prostate cancer to see if the blood test matches the scan findings. The goal is to find a simpler way to moni…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:28 UTC
-
GATA2 gene study aims to predict who will develop leukemia
Knowledge-focused Recruiting nowThis study follows 150 people with a GATA2 gene mutation to learn what early changes in blood and bone marrow might lead to serious blood cancers like leukemia. Researchers will collect blood and bone marrow samples during routine care over 5 years. No new treatments are being te…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC
-
Which blood test spots cancer cells best? new study aims to find out
Knowledge-focused Recruiting nowThis study compares three different blood tests (CellSearch, Parsortix, and SmartCatch) to see which one is best at finding circulating tumor cells in people with metastatic breast or prostate cancer. About 54 patients will give a blood sample before starting a new treatment. The…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:10 UTC
-
Scientists dig into data of 370 kids to crack brain tumor resistance
Knowledge-focused Recruiting nowThis study looks back at data from 370 children and teens treated for ependymoma, a common brain tumor. Researchers want to understand why half of these tumors come back after surgery and radiation. They will use advanced imaging, genetics, and artificial intelligence to find pat…
Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:12 UTC